Brittle Cornea Syndrome
Last Posted: Mar 03, 2023
- Corneal Perforation After Corneal Cross-Linking in Keratoconus Associated With Potentially Pathogenic ZNF469 Mutations.
Zhang Wenlin, et al. Cornea 2019 0 (8) 1033-1039
- Brittle cornea syndrome ZNF469 mutation carrier phenotype and segregation analysis of rare ZNF469 variants in familial keratoconus.
Davidson Alice E, et al. Investigative ophthalmology & visual science 2015 0 (1) 578-86
- Rare, Potentially Pathogenic Variants in ZNF469 Are Not Enriched in Keratoconus in a Large Australian Cohort of European Descent.
Lucas Sionne E M, et al. Investigative ophthalmology & visual science 2017 12 (14) 6248-6256
- Mutations in the zinc finger protein gene, ZNF469, contribute to the pathogenesis of keratoconus.
Vincent Andrea L, et al. Investigative ophthalmology & visual science 2014 9 (9) 5629-35
- Enrichment of pathogenic alleles in the brittle cornea gene, ZNF469, in keratoconus.
Lechner Judith, et al. Human molecular genetics 2014 10 (20) 5527-35
- Population-based meta-analysis in Caucasians confirms association with COL5A1 and ZNF469 but not COL8A2 with central corneal thickness.
Hoehn René, et al. Human genetics 2012 11 (11) 1783-93
- Brittle cornea syndrome
From NCATS Genetic and Rare Diseases Information Center
- Common genetic variants near the Brittle Cornea Syndrome locus ZNF469 influence the blinding disease risk factor central corneal thickness.
Lu Yi, et al. PLoS genetics 2010 5 (5) e1000947
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 09, 2023
- Content source: